Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

ViiV Healthcare

Private
#HIV#Infectious Disease#Antivirals

Global specialist pharmaceutical company researching, developing and delivering medicines to treat and prevent HIV; majority-owned by GSK with Pfizer and Shionogi as shareholders.

Company Info

Sector:Pharmaceuticals / HIV
Headquarters:London, United Kingdom
Founded:2009
Website:viivhealthcare.com/

Funding & Investor Relations

Notable Investors

  • GSK
  • Pfizer
  • Shionogi

IPO Outlook / Plans

Private joint venture; no IPO announced

Clinical Development Pipeline

Cabenuva (cabotegravir + rilpivirine)

Target: Integrase + NNRTI
HIV-1 treatment (long-acting injectable)
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Apretude (cabotegravir)

Target: Integrase
HIV pre-exposure prophylaxis (PrEP)
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Dovato (dolutegravir + lamivudine)

Target: Integrase + NRTI
HIV-1 treatment
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Careers & Job Openings

See all open roles

All departments
See posting
Apply Now →